SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-033873
Filing Date
2024-08-26
Accepted
2024-08-26 16:05:47
Documents
15
Period of Report
2024-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 47170
  Complete submission text file 0001493152-24-033873.txt   270894

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tvgn-20240820.xsd EX-101.SCH 3815
3 XBRL DEFINITION FILE tvgn-20240820_def.xml EX-101.DEF 26691
4 XBRL LABEL FILE tvgn-20240820_lab.xml EX-101.LAB 36844
5 XBRL PRESENTATION FILE tvgn-20240820_pre.xml EX-101.PRE 25315
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6097
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41002 | Film No.: 241241191
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)